Search

everythinglearnresearchcommunity

for

Search:↓

Targeting mitophagy may help treat alopecia areata by reducing inflammasome activation.

Mcl-1 can activate Wnt signaling in skin cells, promoting growth and possibly cancer.

Acne patients have higher mTOR gene expression.

Akt2 protein is essential for normal cell division in early mouse embryos.

Mathematical modeling helps understand and predict the MAPK cell signaling pathway.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

The mTOR pathway may be involved in the development of hair follicle tumors, with higher activity in malignant tumors.

Blocking Oncostatin M's role in the JAK-STAT pathway can stimulate hair growth in mice.

Matriptase is crucial for skin, hair, and immune cell health, and its imbalance can lead to cancer.

Patched1 helps prevent tumors by controlling cell growth.

Mitf plays a key role in melanoma progression and is linked to disease stage.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

ERK activation spreads between cells, influencing cell division and wound healing.

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.

Loss of Rap1 protein speeds up heart aging in mice.

CXCR2 in skin cells promotes tumor growth.

Activating mitophagy may help manage a key immune response involved in the hair loss condition alopecia areata.

Researchers found a new gene variant linked to a rare bone disease, which doesn't always cause symptoms in carriers.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

Decreasing MIG6 can increase the movement and invasiveness of MEK-inhibited mutant NRAS melanoma, particularly when stimulated by EGF.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

MAD2B slows down the growth of skin cells that are important for hair development by interacting with TCF4.

Topical melatonin may reduce skin aging by inhibiting certain cellular pathways.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

A specific molecular switch, driven by MAPK/ERK signaling, helps spiny mice heal wounds by regenerating skin instead of forming scars.

Increasing m6A levels can improve skin cell growth and wound healing.